The Triana Group welcomes Dr. Geert Cauwenbergh as an Advisor. Dr. Cauwenbergh brings a track record that ranges from his position as head of global dermatology R&D at J&J, to successfully launching a biotechnology start-up, financing it through venture capital rounds and listing on the NASDAQ.
The Triana Group welcomes NASDAQ-Listed Barrier Therapeutics Founder Dr. Geert Cauwenbergh as an Advisor.
